# Gel Coat Biomaterials

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gel-coat-biomaterials

- Industry: Biotechnology
- Headquarters: Tokyo, Japan
- Website: www.gelcoatbio.com/
- Total disclosed funding: $1.3M
- Latest round: Series A (Apr 27, 2026)
- Investors on record: 2

## About

Gel Coat Biomaterials, Inc. is a Japan-based company focused on developing innovative hydrogel solutions that enhance the stability and functionality of biomaterials for various applications in medical technology and environmental sustainability.Founded in 2024 in Tokyo, Japan, Gel Coat Biomaterials, Inc. specializes in proprietary gel technologies. The company has successfully raised JPY 200 million in Series A funding, primarily from Soken Chemical & Engineering and WASEDA University Ventures, targeting advancements in hydrogel applications. The firm has completed a total of 2 deals, with the most recent deal taking place on April 27, 2026. The founding team includes Shin Yoshida, who serves as CEO, alongside co-founder Madoka Takai.Gel Coat Biomaterials specializes in their proprietary dual-ion hydrogel technology, known as Gel Coat™, which stabilizes biomaterials like enzymes and cells. This hydrogel is designed to maintain the activity and integrity of biomaterials, with applications in medical technology, environmental sustainability, and resource recycling across North America, Europe, and parts of Asia.Revenue for Gel Coat Biomaterials is generated through partnerships and licensing agreements, allowing clients to utilize Gel Coat™ technology for biomedical applications. The company engages in fee-based licensing models and revenue-sharing agreements, along with direct sales of customized hydrogel solutions tailored for specific medical applications.In April 2026, Gel Coat Biomaterials raised JPY 200 million in Series A funding to enhance its hydrogel technology and scale production. The funds will also support the commercialization of Gel Coat through strategic partnerships while expanding the company's presence in Japan and international markets.

## Funding rounds

- Series A, Apr 27, 2026, $1.3M — WASEDA University Ventures, Soken Chemical & Engineering

## Investors

- WASEDA University Ventures (https://capitalatlas.ai/funds/waseda-university-ventures) — Series A
- Soken Chemical & Engineering — Series A